RHEACELL GmbH & Co. KG
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.rheacell.com
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 250
- Registration Number
- NCT06489028
- Locations
- 🇬🇧
RHEACELL Clinical Trial Site, Multiple Locations, United Kingdom
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 74
- Registration Number
- NCT05838092
- Locations
- 🇺🇸
Masonic Cancer Center and Medical Center Minneapolis, Minneapolis, Minnesota, United States
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 74
- Registration Number
- NCT05464381
- Locations
- 🇦🇹
EB-Haus Austria; Salzburger Landeskliniken (SALK), Salzburg, Austria
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
- Conditions
- Skin Ulcer Venous Stasis Chronic
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 200
- Registration Number
- NCT04971161
- Locations
- 🇩🇪
MVZ Gefäßzentrum Aachen am Marienhospital Aachen GmbH, Aachen, Germany
🇩🇪Universitätsklinikum Augsburg, Klinik für Dermatologie und Allergologie, Campus Süd, Augsburg, Germany
🇩🇪Fachklinik Bad Bentheim, Dermatologische Ambulanz, Bad Bentheim, Germany
Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure
- Conditions
- Acute-On-Chronic Liver Failure
- Interventions
- Biological: allo-APZ2-ACLF
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 5
- Registration Number
- NCT03860155
- Locations
- 🇩🇪
Universitätsklinikum Carl-Gustav-Carus an der TU Dresden, Medizinische Klinik I, Dresden, Germany
🇩🇪Universitätsklinikum Frankfurt, Medizinische Klinik 1, Sektion Translationale Hepatologie, Frankfurt, Germany
🇩🇪Universitätsklinikum Essen, Klinik für Gastroenterologie und Hepatologie, Medizinisches Forschungszentrum, Essen, Germany
Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD
- Conditions
- Limbal Stem Cell Deficiency
- Interventions
- Biological: LSC2
- First Posted Date
- 2018-06-08
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 16
- Registration Number
- NCT03549299
- Locations
- 🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
🇩🇪Universitäts-Klinikum Köln, Augenklinik, Köln, Germany
🇩🇪Universitäts-Klinikum Jena, Augenklinik, Jena, Germany
Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa
- Conditions
- Recessive Dystrophic Epidermolysis Bullosa
- Interventions
- Biological: allo-APZ2-EB
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 16
- Registration Number
- NCT03529877
- Locations
- 🇺🇸
University of Minnesota, Masonic Cancer Center and Medical Center, Minneapolis, Minnesota, United States
🇫🇷Hôpital Saint-Louis; Département de dermatologie, Paris, France
🇩🇪Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany
Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD
- Conditions
- Peripheral Arterial Occlusive Disease
- Interventions
- Biological: allo-APZ2-PAODDrug: Placebo
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 24
- Registration Number
- NCT03339973
- Locations
- 🇩🇪
Universitätsklinikum "Carl Gustav Carus" der TU Dresden, Dresden, Germany
🇦🇹LKH-Univ. Klinikum Graz, Graz, Austria
🇩🇪SRH Klinikum Karlsbad-Langensteinbach GmbH, Karlsbad, Germany
Allogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans"
- Conditions
- Diabetic Neuropathic Ulcer
- Interventions
- Biological: allo-APZ2-DFU
- First Posted Date
- 2017-08-30
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 23
- Registration Number
- NCT03267784
- Locations
- 🇩🇪
St. Josefskrankenhaus Heidelberg GmbH; Klinische Studienabteilung, Heidelberg, Germany
🇩🇪Universitätsmedizin Greifswald; Klinik und Poliklinik für Hautkrankheiten, Greifswald, Germany
🇩🇪Diabetologikum Raab, Privatärztliche Facharztpraxis, Kassel, Germany
Allogeneic ABCB5-positive Stem Cells for Treatment of CVU
- Conditions
- Skin Ulcer Venous Stasis Chronic
- Interventions
- Biological: allo-APZ2-CVU
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- RHEACELL GmbH & Co. KG
- Target Recruit Count
- 31
- Registration Number
- NCT03257098
- Locations
- 🇩🇪
pro scientia med im Mare Klinikum; Department Klinische Forschung und Entwicklung, Kiel, Germany
🇩🇪Universitätsklinikum Erlangen, Hautklinik, Erlangen, Germany
🇩🇪Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Kliniken der Ruhr-Universität Bochum im St. Maria Hilf Krankenhaus, Bochum, Germany